Literature DB >> 7292376

Time course of response to prednisolone in chronic airflow obstruction.

J Webb, T J Clark, C Chilvers.   

Abstract

Nineteen patients with chronic airflow obstruction measured their morning and evening peak expiratory flow (PEF) daily for 28 days. A placebo was taken for the first week and prednisolone 20 mg twice daily was taken for the last three weeks. The mean PEF in 13 patients who responded to prednisolone reached a maximum after eight days' treatment. The majority of the 19 patients had asthma and were thought to represent a typical cross section of patients who would be considered for a trial of oral corticosteroids. Most responsive patients will achieve a maximum response within eight days.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7292376      PMCID: PMC471435          DOI: 10.1136/thx.36.1.18

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion.

Authors:  C A Soutar; J Costello; O Ijaduola; M Turner-Warwick
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

2.  A study of the respiratory effects of prednisone in diffuse airway obstruction.

Authors:  J H CULLEN; W U REIDT
Journal:  Am Rev Respir Dis       Date:  1960-10

3.  A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma.

Authors:  G K Crompton
Journal:  Thorax       Date:  1968-01       Impact factor: 9.139

4.  Corticosteroids in treatment of chronic asthma.

Authors:  S D Walsh; I W Grant
Journal:  Br Med J       Date:  1966-10-01

5.  Interaction of corticosteroids and catecholamines in the treatment of asthma.

Authors:  G M Shenfield; M E Hodson; S W Clarke; J W Paterson
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

6.  Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.

Authors:  J Webb; T J Clark
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

  6 in total
  15 in total

1.  Dose response of patients to oral corticosteroid treatment during exacerbations of asthma.

Authors:  J R Webb
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

2.  Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy.

Authors:  J K Stoller; Z B Gerbarg; A R Feinstein
Journal:  J Gen Intern Med       Date:  1987 Jan-Feb       Impact factor: 5.128

3.  Pitfalls in the diagnosis of asthma.

Authors:  M R Hetzel
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

4.  Pocket-sized device for measuring forced expiratory volume in one second and forced vital capacity.

Authors:  P J Chowienczyk; C P Lawson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

5.  Corticosteroid resistance in chronic asthma.

Authors:  L S Hill
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

6.  Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.

Authors:  J Wiggins; J A Elliott; R D Stevenson; R A Stockley
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

7.  Corticosteroids in chronic bronchitis.

Authors:  R Rudd
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

8.  Asthma and irreversible airflow obstruction.

Authors:  P J Brown; H W Greville; K E Finucane
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

9.  Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.

Authors:  P G Curzon; M A Martin; N J Cooke; M F Muers
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

10.  Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone.

Authors:  J Webb; T J Clark
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.